NCT02792803 - A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 30, 2017

Study Completion Date

September 30, 2017

Conditions

POAGPrimary Open Angle GlaucomaOcular Hypertension

Interventions

DRUG

Xalatan

A prostaglandin analogue used to reduce intraocular pressure in patients diagnosed with glaucoma.

DRUG

Apo-Latanoprost

A prostaglandin analogue used to reduce intraocular pressure in patients diagnosed with glaucoma.

DRUG

Co-Latanoprost

A prostaglandin analogue used to reduce intraocular pressure in patients diagnosed with glaucoma.

Trial Locations (1)

RECRUITING

Opthalmis Diagnostic Services, Toronto